AU2001288238A1 - Methods of modulating activity of dxr - Google Patents

Methods of modulating activity of dxr

Info

Publication number
AU2001288238A1
AU2001288238A1 AU2001288238A AU8823801A AU2001288238A1 AU 2001288238 A1 AU2001288238 A1 AU 2001288238A1 AU 2001288238 A AU2001288238 A AU 2001288238A AU 8823801 A AU8823801 A AU 8823801A AU 2001288238 A1 AU2001288238 A1 AU 2001288238A1
Authority
AU
Australia
Prior art keywords
dxr
methods
modulating activity
modulating
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288238A
Inventor
Deborah D. Jaworski
David J. Payne
Courtney E. Slater-Radosti
Kang Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of AU2001288238A1 publication Critical patent/AU2001288238A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001288238A 2000-08-09 2001-08-09 Methods of modulating activity of dxr Abandoned AU2001288238A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22390900P 2000-08-09 2000-08-09
US60223909 2000-08-09
PCT/US2001/024950 WO2002011673A2 (en) 2000-08-09 2001-08-09 Methods of modulating activity of dxr

Publications (1)

Publication Number Publication Date
AU2001288238A1 true AU2001288238A1 (en) 2002-02-18

Family

ID=22838480

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288238A Abandoned AU2001288238A1 (en) 2000-08-09 2001-08-09 Methods of modulating activity of dxr

Country Status (3)

Country Link
US (2) US20030206892A1 (en)
AU (1) AU2001288238A1 (en)
WO (1) WO2002011673A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007103762A2 (en) * 2006-03-03 2007-09-13 Colorado State University Research Foundation Compositions and methods of use of electron transport system inhibitors
US9119869B2 (en) 2010-04-29 2015-09-01 Ronald J. Shebuski Mucin derived polypeptides
ES2372942B1 (en) * 2010-07-14 2012-12-04 Universidad De Cantabria NEW ENZYME FOR ISOPRENOID BIOSYNTHESIS.
WO2013006444A1 (en) * 2011-07-01 2013-01-10 The George Washington University Compounds for inhibiting 1- deoxy-d-xylulose- 5 - phosphate reductoisomerase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736981A1 (en) * 1998-04-14 1999-10-21 Kyowa Hakko Bio Co., Ltd. Process for producing isoprenoid compounds by microorganisms
DE19935967A1 (en) * 1999-07-30 2001-02-01 Bayer Ag New DNA encoding Arabidopsis thaliana 1-deoxy-D-xylulose-5-phosphate reductoisomerase for identifying modulators of the enzyme that can be used as herbicides, antibiotic or anti-malarial agents

Also Published As

Publication number Publication date
WO2002011673A2 (en) 2002-02-14
WO2002011673A3 (en) 2002-05-16
US20030206892A1 (en) 2003-11-06
US20050096255A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
AU2001276934A1 (en) Methods of modulating fibrosis
AU3867400A (en) Methods of using bioelastomers
AU2001278142A1 (en) Common application metamodel including c/c++ metamodel
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2001252135A1 (en) Therapeutic agents
AU2001260513A1 (en) Microcapsule well treatment
AU4198500A (en) Suture-passing forceps
AU2002222853A1 (en) Therapeutic compounds
AU2002230860A1 (en) Skin desinfectant applicator
AU6364700A (en) Human synthetases
AU2557500A (en) Methods of making compounds
AU2001259702A1 (en) Tissue regrafting
AU2001297541A1 (en) Software enabled wizards
AU2001233208A1 (en) Human sulfatases
AU2001268683A1 (en) Modification of mdm2 activity
AU2001247600A1 (en) Methods of modulating hair growth
AU2002222240A1 (en) Nerve regeneration
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2001286061A1 (en) Applicator
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU2002227925A1 (en) Human beta-defensin-3
AU2001280588A1 (en) Methods of modulating angiogenesis
AU5394300A (en) Tissue engineering
AU2001273903A1 (en) Therapeutic agents
AU2001288238A1 (en) Methods of modulating activity of dxr